Business ❯Corporate Strategy ❯Mergers and Acquisitions ❯Market Expansion

US Market

Sanofi Acquires Blueprint Medicines for $9.1 Billion

Securing Ayvakit licensing reinforces Sanofi’s bid to dominate immunology with a focus on rare diseases

Merck Announces €3 Billion Acquisition of Springworks Therapeutics

Watches of Switzerland Pressured to Shift Listing from London to New York